John Mattick
Director/Board Member chez HEALIUS LIMITED
Profil
John Mattick is an Independent Non-Executive Director at Healius Ltd.
since 2022, a Professor of RNA Biology at The University of New South Wales since 2019, and an Associate Member at the European Molecular Biology Organization.
He was the Chief Executive Officer at Genomics England Ltd.
from 2018 to 2019.
He was also the Director of the Australian Genome Research Facility at The University of Queensland, the Director of The Garvan Institute of Medical Research, and a Scientific Advisor at Biobank Technology Ventures.
Dr. Mattick earned his doctorate degree from Monash University in 1977 and his undergraduate degree from The University of Sydney in 1971.
Postes actifs de John Mattick
| Sociétés | Poste | Début |
|---|---|---|
| HEALIUS LIMITED | Director/Board Member | 31/03/2022 |
| The University of New South Wales | Corporate Officer/Principal | 01/10/2019 |
| European Molecular Biology Organization | Corporate Officer/Principal | - |
Anciens postes connus de John Mattick
| Sociétés | Poste | Fin |
|---|---|---|
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Chief Executive Officer | 01/01/2019 |
| The University of Queensland | Corporate Officer/Principal | - |
The Garvan Institute of Medical Research
 The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Director/Board Member | - |
Biobank Technology Ventures
 Biobank Technology Ventures Investment ManagersFinance Biobank Technology Ventures (Biobank Technology) is a venture capital firm founded in 2001 by Pascal Brandys and Agnes Le Saux-Narjoz. The firm is headquartered in Del Mar, California. | Consultant / Advisor | - |
Formation de John Mattick
| Monash University | Doctorate Degree |
| The University of Sydney | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HEALIUS LIMITED | Health Services |
| Entreprise privées | 4 |
|---|---|
Biobank Technology Ventures
Biobank Technology Ventures Investment ManagersFinance Biobank Technology Ventures (Biobank Technology) is a venture capital firm founded in 2001 by Pascal Brandys and Agnes Le Saux-Narjoz. The firm is headquartered in Del Mar, California. | Finance |
| European Molecular Biology Organization | |
The Garvan Institute of Medical Research
The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Commercial Services |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Commercial Services |
